Product Information
BEXAROTENE 75 MG CAPSULE is a generic product labeled by Actavis Pharma, Inc., priced at $5.6022 per EA under NDC 00591283201. Its NADAC has been published 56 times since Aug 21, 2024.
FDA first approved this application on Jan 14, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
75 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591283201
Classification
Generic
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Effective Date
9/18/2024
Active Ingredients
BEXAROTENEApproval Type
Generic (ANDA)
FDA Application
ANDA209931FDA Approved
1/14/2021
TE Code
AB
On Market Since
11/11/2021
Pharmacological Classes
Price Statistics
The NADAC for BEXAROTENE 75 MG CAPSULE has been published 56 times since Aug 21, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.6022 per EA |
|---|---|
| All-time high | $5.6022 (Sep 10, 2025) |
| All-time low | $5.6022 (Aug 21, 2024) |
| 52-week high | $5.6022 |
| 52-week low | $5.6022 |
| Median price | $5.6022 |
| Average price | $5.6022 |
| Largest weekly change | 0.0% (Aug 28, 2024) |
| Weeks tracked | 56 |
| Tracking since | Aug 21, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
0.0%
3Y
N/A
5Y
N/A
All
0.0%
Last surveyed Sep 10, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BEXAROTENE 75 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for BEXAROTENE 75 MG CAPSULE, manufactured by Actavis Pharma, Inc., is $5.6022 per EA (NDC 00591283201), effective Sep 10, 2025.
How has the price of BEXAROTENE 75 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for BEXAROTENE 75 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 56 weekly CMS publications since Aug 21, 2024.
What are the highest and lowest recorded NADAC prices for BEXAROTENE 75 MG CAPSULE?
Since Aug 21, 2024, the NADAC for BEXAROTENE 75 MG CAPSULE has ranged from a low of $5.6022 (Aug 21, 2024) to a high of $5.6022 (Sep 10, 2025), with a median of $5.6022 per EA.
Are there cheaper alternatives to BEXAROTENE 75 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as BEXAROTENE 75 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures BEXAROTENE 75 MG CAPSULE?
BEXAROTENE 75 MG CAPSULE (NDC 00591283201) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.